Skip to main content
. 2011 Apr;54(2):83–88. doi: 10.1503/cjs.023209

Table 3.

Literature review on PEToma

Study No. patients Focal, no. (%) Diffuse Further examination FNAC/operation Cancer, no. (%) Pathology (micro) SUV
Cohen et al.6 4 525 71 (1.6) 31 NA 15/NA 7 (47.0) 3 PTC
2 poorly differentiated PTC
Useful
Kim et al.9 4 136 45 (1.1) 45 NA 32/7 18 (56.0) 14 PTC
2 metastatic
2 follicular thyroid cancer
NS
Chen et al.7 4 803 60 (1.2) 50 7 (14.0) 7 PTC Useful
Choi et al.8 1 763 70 (4.0) 44 29/NA 17 (38.6) 16 PTC Useful
Are et al.5 8 800 101 (1.1) 162 57 57/27 24 (42.0) 19 PTC NS
Chu et al.11 6 241 76 (1.2) 14/1 4 (28.6) 4 PTC NA
Bogsrud et al.10 7 347 79 (1.1) 48 NA/11 15 (31.3) 12 PTC
2 metastatic
NS
King et al.16 15 711 22 (0.1) 21 21/14 7 (32.0) 6 PTC (4)
1 MTC
NA
Nishimori et al.* 4 726 103 (2.2) 57 50 30/10 9 (30.0) 8 PTC (2)
1 poorly differentiated PTC
NS

FNAC = fine-needle aspiration cytology; MCT = medullary thyroid cancer; NA = not available; NS = not significant; PTC = papillary thyroid cancer; SUV = standardized uptake value.

*

Unpublished data, 2008.